Efficacy of Meld score in predicting survival after liver retransplantation

M. Ravaioli, G. L. Grazi, G. Ercolani, M. Cescon, G. Varotti, M. Del Gaudio, G. Vetrone, A. Lauro, G. Ballardini, A. D. Pinna

Research output: Contribution to journalArticlepeer-review


We retrospectively investigated the efficacy of the MELD score to predict the outcome of liver retransplantation and serve as selection criteria. From 1987 to 2003, the 765 liver transplantations included 87 patients (11.4%) who received a second graft. In addition to graft and patient survivals, ROC curves were used to establish the best MELD score to select cases with poor outcomes. Indications for retransplantation were: 38 (43.7%) surgical complications; 12 (13.8%) chronic rejections; 15 (17.2%) disease recurrences; and 22 (15.3%) primary graft nonfunction. Overall patient survivals at 1, 3, and 5 years were 62.4%, 50.7%, and 49.1%, respectively. A MELD score of 25, calculated by ROC curves, significantly predicted graft and patient survival (44.2% vs 22.5%, P

Original languageEnglish
Pages (from-to)2748-2749
Number of pages2
JournalTransplantation Proceedings
Issue number9
Publication statusPublished - Nov 2004

ASJC Scopus subject areas

  • Surgery
  • Transplantation


Dive into the research topics of 'Efficacy of Meld score in predicting survival after liver retransplantation'. Together they form a unique fingerprint.

Cite this